Your browser version may not work well with NCBI's Web applications. More information here...
1: Curr Rheumatol Rep. 2002 Feb;4(1):39-46.Links

Polymyalgia rheumatica/temporal arteritis: recent advances.

Barilla-LaBarca ML, Lenschow DJ, Brasington RD Jr.

Division of Rheumatology, Washington University School of Medicine, Box 8045, 660 S. Euclid Avenue, St. Louis, MO 63119, USA.

Polymyalgia rheumatica (PMR)/temporal arteritis (TA) frequently causes significant morbidity in patients older than 50 years of age. This review highlights recent trends in clinical findings, epidemiology, pathogenesis, and laboratory and radiologic assessment of the disease. Although steroids are the mainstay of therapy because of their effectiveness and ease of administration, they have numerous side effects, particularly in an aging population. Furthermore, recent evidence suggests that steroids only suppress clinical symptoms, while a smoldering level of damaging vascular inflammation persists. As a result, alternative agents are actively being investigated. We compare their successes and shortcomings and offer insight into their potential role in the treatment of this disease.

PMID: 11798981 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Cyclophosphamide (Cytoxan® , Neosar® )

    Your doctor has ordered the drug cyclophosphamide to help treat your illness. The drug can be taken by mouth in tablet form or be given by injection into a vein.

  • Methotrexate (Rheumatrex® , Trexall® )

    Methotrexate is used to treat severe psoriasis (a skin disease in which red, scaly patches form on some areas of the body) that cannot be controlled by other treatments. Methotrexate is also used along with rest, physica...

  • Mercaptopurine (Purinethol® )

    Your doctor has ordered the drug mercaptopurine to help treat your illness. The drug is taken by mouth in tablet form.

  • » See all 4 drug reports ...
  • Source: AHFS Consumer Medication Information